BRIEF-Labcorp Launches Molecular Residual Disease And Liquid Biopsy Solutions

Reuters
23 Apr
BRIEF-Labcorp Launches Molecular Residual Disease And Liquid Biopsy Solutions

April 23 (Reuters) - Labcorp Holdings Inc LH.N:

  • LABCORP LAUNCHES MOLECULAR RESIDUAL DISEASE AND LIQUID BIOPSY SOLUTIONS

  • LABCORP HOLDINGS - PLASMA DETECT NOW AVAILABLE FOR CLINICAL USE TO ASSESS RISK OF RECURRENCE IN STAGE III COLON CANCER PATIENTS

Source text: ID:nPnXwmPma

Further company coverage: LH.N

((reuters.briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10